Sarcio uses regenerative cartilage cell therapy to treat patients suffering from the effects of Osteoarthritis. Sarcio restores hyaline cartilage and reduces inflammation using an evidence-based induced pluripotent stem cell (iPSC) derived hyaline cartilage cell therapy. The company is also developing an off-the-shelf, injectable, regenerativetherapy to delay or prevent the need for joint replacement.

Biotechnology

Health Care

Therapeutics

Sarcio Inc.

Sarcio Inc.'s headquarters in Minneapolis, MN, United States

Description

People (2)

Jobs (0)

Other offices